BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 4, 2019
Company News

New Year splash as BMS to acquire Celgene in $74B deal

Read More
BioCentury | Jan 4, 2019
Company News

BMS deal weighs on Celgene partners

Read More
BioCentury | Jan 4, 2019
Company News

BMS deal weighs on Celgene partners

Read More
BioCentury | Jan 3, 2019
Company News

New Year splash as BMS to acquire Celgene in $74B deal

Read More
BioCentury | Jul 13, 2018
Clinical News

Acceleron, Celgene score second win with latest luspatercept readout

Read More
BioCentury | Jul 10, 2018
Clinical News

Latest luspatercept readout a second win for Acceleron, Celgene

Read More
BioCentury | Jun 29, 2018
Clinical News

Celgene, Acceleron planning submissions for luspatercept

Read More
BioCentury | Jun 28, 2018
Clinical News

Celgene, Acceleron planning submissions for luspatercept

Read More
BioCentury | Jan 6, 2018
Finance

Watch and wait

Buysiders’ dim views of the big caps heading into 2018
Read More
BioCentury | Jan 4, 2018
Company News

Management tracks: Acceleron, Selecta

Read More
Items per page:
1 - 10 of 54